Glycine, N-methyl-, hydrochloride (1:1) → HCID 10208081, compound
Reaction equation
ClC1C=C(CC(O)=O)C=C(Cl)C=1OC1C=CC(NC(=O)C(C)C)=C(Br)C=1.Cl.CNCC(O)=O.C[N:35]([C:40](=[O:64])[CH2:41][C:42]1[CH:47]=[C:46]([Cl:48])[C:45]([O:49][C:50]2[CH:55]=[CH:54][C:53]([NH:56][C:57](=[O:61])[CH:58]([CH3:60])[CH3:59])=[C:52]([Br:62])[CH:51]=2)=[C:44]([Cl:63])[CH:43]=1)[CH2:36][C:37]([OH:39])=[O:38]>>[Cl:48][C:46]1[CH:47]=[C:42]([CH2:41][C:40]([NH:35][CH2:36][C:37]([OH:39])=[O:38])=[O:64])[CH:43]=[C:44]([Cl:63])[C:45]=1[O:49][C:50]1[CH:55]=[CH:54][C:53]([NH:56][C:57](=[O:61])[CH:58]([CH3:60])[CH3:59])=[C:52]([Br:62])[CH:51]=1Participants
4
Procedure
3,5-Dichloro-4-(3-bromo-4-isobutyramidophenoxy)phenylacetic acid (56 mg) was coupled with methyl glycine hydrochloride (31 mg) using the method described in Example 9. This gave methyl N-[3,5-dichloro-4-(3-bromo-4-isobutyramidophenoxy)phenylacetyl]-glycine, which was hydrolyzed using the method described in Example 1(i) and purified as in Example 9, to give 14 mg (22%) of N-[3,5-dichloro-4-(3-bromo-4-isobutyramidophenoxy)phenylacetyl]glycine, m/z 518.
Workup
- custompurified as in Example 9
Sources & evidence
- ORD record
- ord-2b119bfa0b2f4c4c97f921aac5c25df9
- Source dataset
- uspto-grants-2007_04
- Patent number
- US07199265B2
Reaction notes
Loading…